Apoptosis: target for novel drugs

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Apoptotic cell death pathways are crucial targets for novel drug discovery and development.
• Existing therapies selectively induce apoptosis in cancer cells, with numerous pro-apoptotic drugs in development.
• Anti-apoptotic drugs are advanced for acute conditions like stroke, myocardial infarction, and sepsis, where apoptosis is well-defined.

Purpose of the Study:

• To explore the therapeutic potential of targeting apoptotic cell death pathways.
• To review the current landscape of pro-apoptotic and anti-apoptotic drug development.
• To identify future directions for drug discovery related to apoptosis in both acute and chronic diseases.

Main Methods:

• Review of existing literature on apoptosis pathways and drug development.
• Analysis of marketed and investigational drugs targeting apoptosis.
• Examination of preclinical and clinical data for anti-apoptotic agents in acute diseases.

Main Results:

• Targeted therapies inducing apoptosis in cancer are established, with ongoing development of pro-apoptotic drugs.
• Anti-apoptotic drugs show promise for acute indications like stroke and sepsis, supported by animal model data.
• Understanding apoptosis in chronic disorders presents future opportunities for novel therapeutic interventions.

Conclusions:

• Targeting apoptosis is a validated strategy for cancer therapy and shows promise for acute diseases.
• Further research into apoptotic pathways in chronic conditions could yield novel therapeutic approaches.
• Apoptosis modulation represents a significant area for future pharmaceutical innovation.